Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type |
Therapeutic or Technology![]() |
Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
Stroke | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
IND | |
Blood Cancer | Adult Stem Cell | Donor cell therapy | Angiocrine |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Retinitis Pigmentosa | Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Spinal Cord Injury | Embryonic Stem Cell | Donor cell therapy | Lineage Cell |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Donor cell therapy | ExCellThera Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Alpha Thalassemia Major | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Thymic Disorder, 22q11 Deletion/DiGeorge |
Embryonic Stem Cell, iPS Cell |
Donor cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Huntington's Disease | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
IND | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Spinal Cord Injury | Adult Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Development Candidate | |
Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Medeor Therapeutics |
![]() |
Clinical Trial, Phase 3 | |
Dementia | iPS Cell | Donor cell therapy | Gladstone |
![]() |
Development Candidate, Proof of Concept | |
Sickle Cell Disease | Adult Stem Cell | Donor cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Intestinal Disease, Neurological Disorders |
iPS Cell | Donor cell therapy | CHLA |
![]() |
Pre-IND/IDE or Equivalent | |
Type 1 diabetes | Embryonic Stem Cell | Donor cell therapy | ViaCyte |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Epilepsy | Embryonic Stem Cell | Donor cell therapy | Neurona Therapeutics |
![]() |
Pre-IND/IDE or Equivalent | |
Type 1 diabetes | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
COVID-19, Respiratory Disorders |
Adult Stem Cell | Donor cell therapy | Celularity Inc |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Inflammatory bowel disease | Adult Stem Cell | Donor cell therapy | Vitabolus, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Beta Thalassemia, Sickle Cell Disease |
Adult Stem Cell | Diagnostic Test | CHORI |
![]() |
Regulated Lab Test, Ready for Validation | |
Beta Thalassemia, Sickle Cell Disease |
Adult Stem Cell | Diagnostic Test | UCSF |
![]() |
Regulated Lab Test, Ready for Validation | |
COVID-19, Respiratory Disorders |
Vital Research Opportunity | Convalescent Plasma | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Embryonic Stem Cell | Cell processing & handling | Stanford |
![]() |
Research Insights | ||
Parkinson's Disease | iPS Cell | Cell processing & handling | Aspen Neuroscience | Research Insights, Tool/Resources/Bottleneck | ||
Amyotrophic Lateral Sclerosis, Spinal Cord Injury |
Embryonic Stem Cell, iPS Cell |
Cell imaging & tracking | UCSD |
![]() |
Research Insights | |
Other | Embryonic Stem Cell | Cell imaging & tracking | UC Berkeley |
![]() |
Tool/Resources/Bottleneck | |
COVID-19 | iPS Cell | Cell delivery or targeting | UCSD |
![]() |
Tool/Resources/Bottleneck | |
Age-related macular degeneration | Embryonic Stem Cell | Biologic | USC |
![]() |
Pre-IND/IDE or Equivalent | |
Vascular Disease | Adult Stem Cell | Biologic | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
COVID-19, Respiratory Disorders |
Adult Stem Cell | Biologic | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Severe Combined Immunodeficiency, X-linked (X-SCID) | Adult Stem Cell | Antibody | Jasper Therapeutics, Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
B cell cancers, Leukemia |
Cancer Stem Cell | Antibody | UCSD |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 |
Pages
- « first
- ‹ previous
- 1
- 2
- 3